UroGen Pharma Ltd. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
UroGen Pharma Ltd. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • UroGen Pharma Ltd. Operating Lease, Payments for the quarter ending March 31, 2024 was $277K, a 5.78% decline year-over-year.
  • UroGen Pharma Ltd. annual Operating Lease, Payments for 2023 was $1.17M, a 2.18% decline from 2022.
  • UroGen Pharma Ltd. annual Operating Lease, Payments for 2022 was $1.2M, a 8.08% decline from 2021.
  • UroGen Pharma Ltd. annual Operating Lease, Payments for 2021 was $1.3M, a 24.7% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.17M -$26K -2.18% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $1.2M -$105K -8.08% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $1.3M -$426K -24.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $1.73M +$534K +44.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $1.19M Jan 1, 2019 Dec 31, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.